NCT06720623

Brief Summary

This is an observational, retrospective, single-center study focused on the diagnosis of Central Precocious Puberty in female patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
213

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 25, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 6, 2024

Completed
Last Updated

December 6, 2024

Status Verified

October 1, 2024

Enrollment Period

2.6 years

First QC Date

December 3, 2024

Last Update Submit

December 3, 2024

Conditions

Keywords

Central Precocious Puberty

Outcome Measures

Primary Outcomes (1)

  • LH value

    basal Lh value, and LH peak value after stimulus test with GnRH (mU/mL )

    at baseline

Secondary Outcomes (5)

  • Uterine volume

    at baseline

  • Longitudinal uterine diameter

    at baseline

  • Presence of endometrial rhyme

    at baseline

  • Ratio of peak LH/FSH values

    at baseline

  • peak LH (mU/mL) value / FSH value ( mU/mL)

    at baseline

Eligibility Criteria

AgeUp to 8 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Female patients undergoing GnRh testing for suspected diagnosis of Central Early Puberty between january 2017 and December 2020 at the Pediatrics Unit of IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola.

You may qualify if:

  • Female patients with onset of signs of early pubertal development (onset of telarche) before the age of 8 years, who referred to the Pediatrics Unit of IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola between January 2017 and December 2020;
  • Female patients undergoing GnRh testing for suspected diagnosis of Central Early Puberty between january 2017 and December 2020;
  • Obtaining informed consent from parents/legal guardian of pediatric patients.

You may not qualify if:

  • Patients with Peripheral precocious puberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, 40138, Italy

Location

Related Links

MeSH Terms

Conditions

Puberty, Precocious

Condition Hierarchy (Ancestors)

Gonadal DisordersEndocrine System Diseases

Study Officials

  • Federico Baronio, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2024

First Posted

December 6, 2024

Study Start

May 25, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

December 6, 2024

Record last verified: 2024-10

Locations